Shehaj, I.; Krajnak, S.; Almstedt, K.; Degirmenci, Y.; Herzog, S.; Lebrecht, A.; Linz, V.C.; Schwab, R.; Stewen, K.; Brenner, W.;
et al. BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 2024, 12, 1361.
https://doi.org/10.3390/biomedicines12061361
AMA Style
Shehaj I, Krajnak S, Almstedt K, Degirmenci Y, Herzog S, Lebrecht A, Linz VC, Schwab R, Stewen K, Brenner W,
et al. BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines. 2024; 12(6):1361.
https://doi.org/10.3390/biomedicines12061361
Chicago/Turabian Style
Shehaj, Ina, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner,
and et al. 2024. "BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer" Biomedicines 12, no. 6: 1361.
https://doi.org/10.3390/biomedicines12061361
APA Style
Shehaj, I., Krajnak, S., Almstedt, K., Degirmenci, Y., Herzog, S., Lebrecht, A., Linz, V. C., Schwab, R., Stewen, K., Brenner, W., Hasenburg, A., Schmidt, M., & Heimes, A.-S.
(2024). BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines, 12(6), 1361.
https://doi.org/10.3390/biomedicines12061361
